EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes

Christian Schulte, Bhawana Singh, Konstantinos Theofilatos, Nils A Sörensen, Jonas Lehmacher, Tau Hartikainen, Paul M Haller, Dirk Westermann, Tanja Zeller, Stefan Blankenberg, Johannes T Neumann, Manuel Mayr

Journal of Molecular and Cellular Cardiology Plus · 2022

DOI: 10.1016/j.jmccpl.2022.100014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular and Cellular Cardiology Plus, 2022. Verfasst von Christian Schulte und 11 weiteren Autor:innen. Beteiligte Einrichtung: King's British Heart Foundation Centre, King's College London, United Kingdom. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: British Heart Foundation, DZHK, King's College London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While cardiac-specific troponin (cTn) allows for rapid diagnosis of acute type 1 myocardial infarction (T1MI), its performance to differentiate acute myocardial injury (AI) or type 2 myocardial infarction (T2MI) is limited. The objective was to combine biomarkers to improve discrimination of different myocardial infarction (MI) aetiologies.

Methods

We determined levels of cardiac troponin T and I (cTnT, cTnI), cardiac myosin-binding protein C (cMyBP-C), NT-proBNP and ten miRNAs, known to be associated with cardiac pathology in a total of n = 495 serial plasma samples at three time points (on admission, after 1 h and 3 h) from 57 NSTEMI (non-ST-elevation myocardial infarction), 18 AI, and 31 STEMI patients, as defined by fourth universal definition of MI (UDMI4) and 59 control individuals. We then applied linear mixed effects model to compare the kinetics of all molecules in these MI sub-types.

Results

Established (cTnT, cTnI) and novel (cMyBP-C) cardiac necrosis markers failed in differentiating T1MI vs T2MI at early time points. All cardiac necrosis markers were higher in T1MI than in T2MI at 3 h after admission. Muscle-enriched miRNAs (miR-1 and miR-133a) were correlated with cardiac necrosis protein markers and did not offer better discrimination. Established cardiac strain marker NT-proBNP differentiated AI and T1MI at all time points but failed to discriminate T2MI from T1MI. However, the combination of NT-proBNP and cTnT along with age returned an overall AUC of 0.76 [95 % CI 0.67-0.84] for differentiating T1MI, T2MI and AI.

Conclusions

Rather than using single biomarkers of myocardial necrosis, a combination of clinical biomarkers for cardiac necrosis (troponin) and cardiac strain (NT-proBNP) might aid in differentiating T1MI, T2MI and AI.

Schlagwörter

Stichwörter der Autor:innen

Acute injuryBiomarkersCardiac myosin-binding protein CMyocardial infarction type 2NT-proBNPTroponinmicroRNA

Autor:innen und Institutionen

  • King's British Heart Foundation Centre, King's College London, United Kingdom.
  • Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Centre of Cardiovascular Research (DZHK), Partner Site Hamburg, Luebeck, Kiel, Hamburg, Germany.
  • Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • University Center of Cardiovascular Science, Hamburg, Germany.
  • Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Förderung

  • British Heart Foundation
  • DZHK
  • King's College London
  • DFG
  • Abbott Diagnostics
  • Fondation Leducq
  • Deutsche Herzstiftung
  • National Institute for Health and Care Research

Zitieren

APA

Schulte, C., Singh, B., Theofilatos, K., Sörensen, N. A., Lehmacher, J., Hartikainen, T., Haller, P. M., Westermann, D., Zeller, T., Blankenberg, S., Neumann, J. T., & Mayr, M. (2022). Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes. Journal of Molecular and Cellular Cardiology Plus. https://doi.org/10.1016/j.jmccpl.2022.100014

Vancouver

Schulte C, Singh B, Theofilatos K, Sörensen NA, Lehmacher J, Hartikainen T, et al. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes. Journal of Molecular and Cellular Cardiology Plus. 2022. doi:10.1016/j.jmccpl.2022.100014

BibTeX
@article{Schulte2022,
  author = {Schulte, Christian and Singh, Bhawana and Theofilatos, Konstantinos and Sörensen, Nils A and Lehmacher, Jonas and Hartikainen, Tau and Haller, Paul M and Westermann, Dirk and Zeller, Tanja and Blankenberg, Stefan and Neumann, Johannes T and Mayr, Manuel},
  title = {Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes},
  journal = {Journal of Molecular and Cellular Cardiology Plus},
  year = {2022},
  doi = {10.1016/j.jmccpl.2022.100014}
}
Kostenlos starten →